The development comes after the subject expert committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) recommended Oxford-AstraZeneca’s vaccine for emergency use and Covaxin for restricted use.
source https://www.hindustantimes.com/india-news/drugs-regulator-chief-s-press-conference-today-approval-of-covid-19-vaccines-likely/story-yfwScMM7lon56sv0J1FaBM.html
No comments:
Post a Comment